Results 161 to 170 of about 42,673 (234)

Antitumor Activity of Death Receptor 5-Targeted Camptothecin-Loaded Nanoparticles in Murine Syngeneic Models. [PDF]

Biomacromolecules
Boland AJ, Greene MK, Herron ÚM, Johnston MC, Smyth P, Yagita H, Longley DB, Scott CJ.   +7 more
europepmc   +1 more source

Camptothecin Analogue TLC388 [PDF]

, 2020
openaire   +1 more source

USP37 prevents premature disassembly of stressed replisomes by TRAIP. [PDF]

Nat Commun
Kochenova OV, D'Alessandro G, Pilger D, Schmid E, Richards SL, Garcia MR, Jhujh SS, Voigt A, Gupta V, Carnie CJ, Alex Wu R, Gueorguieva N, Lam S, Stewart GS, Walter JC, Jackson SP.   +15 more
europepmc   +1 more source

Mining the Hidden Pharmacopeia: Fungal Endophytes, Natural Products, and the Rise of AI-Driven Drug Discovery. [PDF]

Int J Mol Sci
Al Shami R, Mousa WK.
europepmc   +1 more source

Silencing of SOD1 sensitises ATRX-deficient cells to camptothecin treatment through increased activity of the alternative lengthening of telomeres pathway. [PDF]

Hum Mol Genet
Mattis N, Goncalves T, Kim K, Hammond EM, Rose AM.   +4 more
europepmc   +1 more source

Research progress of plant-derived chemical compounds for overcoming pancreatic cancer drug resistance. [PDF]

World J Gastroenterol
Yu JQ, Yu SJ, He YH, Xue YZ, Yu XF, Chen W, Hu LY, Fan XF, Gao ZF, Zhou HK, Liu XR, He XS, Wang XG.   +12 more
europepmc   +1 more source

FOSL1 promotes homologous recombination repair and camptothecin resistance via TCOF1-mediated ribosome biogenesis in non-small cell lung cancer. [PDF]

Transl Oncol
Hao C, Chen L, Liao F, Chen L, Yao Y, Song Q.   +5 more
europepmc   +1 more source

Construction of aptamer functionalized camptothecin incorporated chitosan-palladium/gold nanoparticles delivery improved photothermal activity and anti-lung carcinoma cells. [PDF]

J Mater Sci Mater Med
Wang Z, Ye M, Wang C, Ma D, Zhang J, Fang F.   +5 more
europepmc   +1 more source

A novel radiosensitizer α-sulfoquinovosyl-acylpropanediol (SQAP) inhibits DNA repair pathways and sensitize cells to cancer chemotherapeutic agents. [PDF]

Sci Rep
Maeda J, Sunada S, Fukuhara T, Kato TA.
europepmc   +1 more source